Summary
91 / 100 · Bulios Score
What speaks for it
- Out of every 100 SAR of revenue, 22 SAR is left as net profit.
- Earnings per share grew by 18% a year over the last 3 years.
- You pay 10.3 SAR for 1 SAR of yearly profit, little for its sector.
What to watch
None of the indicators we track raises a caution right now.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapP/E against the industry (Medical - Care Facilities)
Today you pay 10.3 SAR for 1 SAR of yearly profit.
Valuation in detailIs it growing?
Yes, fastRevenue (SAR)
Diluted EPS (SAR)
Revenue grew by 12% a year over the last 3 years. Earnings per share grew by 18% a year over the last 3 years.
Growth in detailDoes it make money?
Income figures for the last 12 months are not available.
Profitability in detailIs it financially healthy?
YesIt holds more cash than debt.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detail